High‑dose versus standard oral terbinafine for treating tinea capitis in children
- Substances:Terbinafine
France- Participants:0–17 years
- Substances:Terbinafine
- Sponsor:Centre Hospitalier Regional Universitaire De Tours
Rare diseases
Investigational molecules
Locations
Back to France3 430 clinical trials in Argenteuil, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)
FranceDurvalumab with chemotherapy drug combination versus surveillance in patients with low‑risk localized stomach or gastroesophageal junction cancer
FranceLong‑term safety and tolerability of oral nizubaglustat in patients with rare lysosomal disorders who have completed a prior study
FranceStudy of Encaleret Hemisulfate Hemihydrate for Efficacy, Safety and Tolerability in Adults with Chronic Hypoparathyroidism
FrancePhase 3 Trial Evaluating Inhaled Mosliciguat for Safety, Efficacy, and Exercise Capacity in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
FranceStudy of risankizumab plus anti‑α4β7 integrin antibody versus each alone in adults with moderately to severely active Crohn’s disease or ulcerative colitis
FranceMaintenance Treatment Study of gsk5733584 with dostarlimab or pembrolizumab in patients with mismatch repair proficient advanced or recurrent endometrial cancer
FranceMiglustat oral solution safety and efficacy study in pediatric patients with CLN3 disease
FranceSafety and Tolerability of Intrathecal CMP-002 in Participants with SYNGAP1-Related Disorder
FranceStudy of Bexmarilimab with Azacitidine versus Placebo with Azacitidine in Treatment‑Naïve Higher‑Risk Myelodysplastic Syndrome Patients
FranceSafety and Efficacy of GSK5764227 with Abiraterone Acetate and Enzalutamide in Metastatic Castration‑Resistant Prostate Cancer Patients
FranceStudy on the effectiveness of dexamethasone and chloroprocaine in extending the effects of spinal anesthesia for patients undergoing knee arthroscopy
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on multiple myeloma and various lymphomas, evaluating novel treatment combinations and maintenance therapies. Studies include investigations of follicular lymphoma and chronic lymphocytic leukemia treatments.
Particular emphasis on improving patient outcomes through targeted therapies and immunological approaches.
Clinical trials examining treatments for invasive candidiasis and immune system disorders. Research includes studies on immunosuppression prevention and management in intensive care settings.
Focus on developing more effective treatments for both acute and chronic immune conditions.
Studies investigating treatments for asthma and severe respiratory infections, including community-acquired pneumonia. Research includes evaluation of new delivery systems and therapeutic approaches.
Emphasis on improving treatment outcomes and patient quality of life through innovative therapeutic strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.